Gleaning relapse risk from B cell phenotype: decreased CD5(+) B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis

Παρόμοια τεκμήρια

• Decreased CD5(+) B Cells in Active ANCA Vasculitis and Relapse after Rituximab
  ανά: Bunch, Donna O’Dell, κ.ά.
  Έκδοση: (2013)
• Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis
  ανά: Poulton, Caroline J., κ.ά.
  Έκδοση: (2013)
• What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population
  ανά: Berg, Elisabeth A.B., κ.ά.
  Έκδοση: (2014)
• Predictors of Treatment Outcomes in ANCA-Associated Vasculitis with Severe Kidney Failure
  ανά: Lee, Taewoo, κ.ά.
  Έκδοση: (2014)
• Treatment of Relapses in ANCA-Associated Vasculitis
  ανά: McClure, Mark, κ.ά.
  Έκδοση: (2019)